Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News
|
Wade Roush |
11/19/09 |
Boston
|
|
Alkermes to Seek FDA Approval of Anti-Addiction Drug
|
Ryan McBride |
11/16/09 |
Boston
|
|
Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/14/09 |
Boston
|
|
Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test
|
Luke Timmerman |
10/13/09 |
Boston
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News
|
Ryan McBride |
09/30/09 |
Boston
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Alkermes’ Ambitious Builder, Richard Pops, Grabs Reins to Re-Ignite Growth Phase
|
Luke Timmerman |
09/28/09 |
Boston
|
|
Acceleron Aims for Anemia Cure, Mascoma to Pump Out Biofuels For Chevron, Genzyme Chief to Head Boston Fed, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/16/09 |
Boston
|
|
aTyr Pharma Raises $12 Million in Venture Funding
|
Eric Hal Schwartz |
07/28/09 |
San Diego
|
|
Amylin’s Would-Be Savior, Once-Weekly Diabetes Shot, Shows Two-Year Benefit
|
Luke Timmerman |
06/07/09 |
San Diego
|
|
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/20/09 |
Boston
|
|
FDA OKs Risperdal Consta for Bipolar
|
Luke Timmerman |
05/18/09 |
Boston
|
|
Diabetes Drug Application May Be New Factor in Amylin Proxy Battle
|
Juha-Pekka Tikka |
05/05/09 |
San Diego
|
|
Merck Makes GlycoFi Center of its Biogenerics Strategy, Biogen Says Tysabri Might Promote Remyelination, Stemgent Teams with Fate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/30/09 |
Boston
|
|
Alkermes Moving to Waltham
|
Luke Timmerman |
04/22/09 |
Boston
|
|
Epizyme Unveils Technology, Targeting Cancer with Epigenetic Drugs
|
Ryan McBride |
04/20/09 |
Boston
|
|
Clinical Data Sheds Cogenics, Codon Devices Codes, Mass Medical Angels Revs Up, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/08/09 |
Boston
|
|
Alkermes, Swinging For the Fence, Touts New Anti-Addiction Drug
|
Luke Timmerman |
04/07/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Selecta Biosciences Banks $15M to Advance Nano-Sized Immune-Stimulating Drugs
|
Ryan McBride |
02/25/09 |
Boston
|
|
Alkermes Aims for Big Time, Partners Launches Blood Pressure Tracker, Synta Gets GSK Payday, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
02/18/09 |
Boston
|
|
Alkermes Knocks on Door of Biotech Big Leagues, Aims to Make Drugs of its Own
|
Luke Timmerman |
02/12/09 |
Boston
|
|
More Info Needed on Alkermes Drug
|
Ryan McBride |
02/11/09 |
Boston
|
|
Vertex Stays Put, Hydra Handed $22M, Sequenom Still Pursuing Exact Sciences Acquisition, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/21/09 |
Boston
|
|
How to Survive the Downturn: Five Questions With Boston Biotech Leaders, Part 2
|
Luke Timmerman |
01/16/09 |
Boston
|
|
Amylin Shares Soar as Diabetes Drug Catches a Break From FDA
|
Luke Timmerman |
12/11/08 |
San Diego
|
|
Alkermes Regains Vivitrol Rights, Biogen Idec Heads for the Burbs, A Peek at Partners Innovation Fund’s Portfolio, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/03/08 |
Boston
|
|
Alkermes Gets Alcohol Drug Rights From Cephalon
|
Luke Timmerman |
12/01/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
